Full-Service, Fully Committed
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Drug Products, and associated Packaging Services. Through a growing network of focused investments across Europe and the US organized under Technology Platforms, CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
CordenPharma’s vertically-integrated supply chain model provides development & manufacturing expertise spanning the complete cGMP supply chain > from regulated raw materials through intermediates, APIs, commercial-scale Drug Product manufacturing, finished dosage formulation, packaging, clinical trial services, & pharma logistics > resulting in reduced development & manufacturing time and cost.
News & Press
- November 23, 2020
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.
- November 17, 2020
Press Release > CordenPharma Increases Centre of Excellence for Peptide Development Capacity.
- November 16, 2020
News > CordenPharma Congratulates Moderna on positive Phase 3 results of mRNA-1273 COVID-19 vaccine.
CUSTOMER VIDEO > Your ONE PARTNER CDMO for Integrated Supply
Customer Video > WATCH IT HERE
Browse our library of Brochures, Product Lists, White Papers, Videos & Webinars.
Place an inquiry here > one of our team of experts will get back to you.